1-3 of 3
Wilhelm Oberaigner
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Non-Pegylated Liposomal Encapsulated Doxorubicin Reduces Cardiotoxicity in 1st Line Treatment of Diffuse Large B-Cell Lymphoma (DLBCL). Final Results of a Randomized Trial

Free
Michael A. Fridrik, MD, Andreas L Petzer, M.D., Felix Keil, MD, Wolfgang Willenbacher, MD, Ulrich Jaeger, MD, Alois Lang, MD, Sonja Burgstaller, MD, Johannes Andel, MD, Otto Krieger, M.D., Wilhelm Oberaigner, Richard Greil, MD
Journal: Blood
Blood (2011) 118 (21): 2676.
https://doi.org/10.1182/blood.V118.21.2676.2676
Published: 2011
Journal Articles

Is Liposome Encapsulated Doxorubicin Able to Reduce the Cardiotoxicity of Doxorubicin In the Treatment of DLBCL? A Randomised Study by the Austrian Working Party of Medical Oncology (AGMT-study NHL-14)

Free
Michael Fridrik, MD, Andreas L Petzer, MD, Felix Keil, MD, Wolfgang Willenbacher, MD, Ulrich Jäger, MD, Alois Lang, MD, Johannes Andel, MD, Otto Krieger, MD, Wilhelm Oberaigner, Richard Greil, MD
Journal: Blood
Blood (2010) 116 (21): 1766.
https://doi.org/10.1182/blood.V116.21.1766.1766
Published: 2010
Journal Articles

Molecular Remission after Induction Chemo- Immunotherapy and Rituximab Maintenance in Previously Untreated Follicular Lymphoma.

Free
Michael A Fridrik, MD, Richard Greil, Georg Hopfinger, MD, Christine Mannhalter, Wilhelm Oberaigner, Ulrich Jaeger, MD
Journal: Blood
Blood (2009) 114 (22): 2724.
https://doi.org/10.1182/blood.V114.22.2724.2724
Published: 2009